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Visceral adipose tissue (AT) inflammation is linked to the complications of obesity, including insulin resistance (IR) and type 2
diabetes. Recent data from our lab showed that germline deficiency in STAT4 reduces inflammation and improves IR in obese
mice. The objective of this study was to determine the contribution of selective STAT4 deficiency in subsets of hematopoietic cells
to IR and AT inflammation. To determine the contribution of hematopoietic lineage, we sublethally irradiated Stat4−/−C57Bl6mice
and reconstituted themwith bone marrow cells (BMC) from Stat4+/+C57Bl6 congenic donors. We also established the contribution
of selective STAT4 deficiency in CD4+ or CD8+ T cells using adoptive transfer in Rag1−/− mice. All mice received a HFD for
15 weeks (𝑛 = 7–12 mice/group). BMC that expressed STAT4 induced increases in glucose intolerance and IR compared to
STAT4-deficient cells. Also, AT inflammation was increased and the numbers of CD8+ cells infiltrating AT were higher in mice
with STAT4 expressing BMC. Studies in Rag1−/− mice further confirmed the prominent role of CD8+ cells expressing STAT4 in
insulin resistance and AT and islet inflammation. Collectively our results show specific and dominant contribution of STAT4 in the
hematopoietic compartment to metabolic health and inflammation in diet-induced obesity.
1. Introduction
Inflammation and activation of the immune system in obesity
are emerging as key contributors associated with type 2
diabetes and cardiovascular disease. Activation of various
inflammatory pathways in visceral adipose tissue (AT) in
obesity was recently identified as an early indicator of insulin
resistance and type 2 diabetes and as a contributor to disease
susceptibility and progression [1].
AT is a heterogeneous tissue and multiple cell types
become dysfunctional with increased adipose mass. Proin-
flammatory cytokine and chemokine production is increased
in hypertrophied adipocytes, in activated macrophages, and
in T cell subsets infiltrating adipose tissue in obesity [2].
In turn, inflammatory mediators produced in AT contribute
to adipocyte metabolic dysfunction resulting in increased
lipolysis and impaired glucose uptake, which can induce
pancreatic beta cell dysfunction, insulin resistance, and
atherosclerosis [3–6].
One of the pathways activated in chronic AT inflamma-
tion is the IL12/STAT4 pathway [7, 8]. STATs are downstream
of the Jak/Tyk tyrosine kinases and act as transcription factors
inducing expression of genes involved in proliferation and
differentiation of various hematopoietic and nonhematopoi-
etic cells [9, 10]. The role of STAT4 was best characterized as
one of the drivers of Th1 polarization and NK cell activation
[11, 12]. However, STAT4 is also present in macrophages
and dendritic cells and mediates production of IFN𝛾 or
other proinflammatory cytokines in response to IL12/IL18 or
adiponectin [13–15].
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Our group recently reported expression of STAT4 in
adipocytes and increased STAT4 activation in visceral adi-
pose tissue in rodent obesity [16, 17]. Also, we reported that
STAT4 global deletion reduces insulin resistance and adipose
tissue inflammation in obesity in part by reducing adipocyte
hypertrophy, infiltration of immune cells, by promoting M2-
biased macrophage polarization, and by improving insulin
signaling in adipose tissue [17].
In this paper we sought to more clearly define the role of
selective STAT4-deficiency in subsets of hematopoietic cells
versus adipocytes.We found that Stat4−/− deficiency in bone
marrow cells rendered the recipientmice less insulin resistant
and glucose intolerant. We identified increased numbers of
CD8+ cells, increased numbers of Mac-2 positive crown-
like structures, and adipocyte hypertrophy in visceral adipose
tissue of Stat4+/+ hematopoietic recipients, despite STAT4
deficiency in adipocytes.
To further establish the role of STAT4-deficiency in T
cell subsets, we adoptively transferred STAT4-deficient CD4+
or CD8+ cells in Rag1−/− mice. Rag1 null mice are lacking
mature T, NKT, and B cells [18], have functional antigen
presenting cells and, similarly to C57Bl6/J mice, become
obese and insulin resistant in response to high fat diet [19]. In
this studyRag1−/−micewere used for selective reconstitution
with STAT4-deficient or STAT4-sufficient T cell subsets and
challenged with high dietary fat. We found that glucose
tolerance was improved only in Stat4−/− CD8+ recipients on
high fat diet and this was likely due to an insulinotropic effect.
These studies highlight the importance of STAT4 in
subsets of hematopoietic cells and its contribution to inflam-
mation and insulin resistance in obesity.
2. Materials and Methods
2.1. Animals and In Vivo Protocols. All procedures involving
animals were approved by the IACUC of Eastern Virginia
Medical School. Male C57Bl/6J mice and Rag1−/−mice were
purchased from Jackson Laboratories (Bar Harbor, ME).
Stat4−/− C57Bl/6J mice (gift from Dr. Mark Kaplan from
Indiana University) and littermate controls were bred in
the EVMS facility. We applied 2 in vivo protocols (Supple-
mental Figure 1 in Supplementary Material available online
at https://doi.org/10.1155/2017/5420718). In Protocol 1, male
Stat4−/− C57Bl/6J and littermate controls, 8 weeks old, were
sublethally irradiated using 2 irradiation regimens of 6Gy
each with a 4-hour interval between irradiation processes
(orthovoltage X-ray machine). Immediately following irradi-
ation mice were transplanted via tail vein injection with 2.5 ×
107 bonemarrow cells collected from tibial and femoral bones
of either Stat4−/− C57Bl/6J mice or C57Bl/6J mice, 8–10
weeks old. Mice were allowed to fully recover for 4 weeks and
were subsequently switched to a high fat diet (60% kcal fat,
Research Diets, New Brunswick, NJ) for 15 additional weeks.
All of themice were between 27-28 weeks of age at euthanasia
(𝑛 = 8/group). In Protocol 2, male Rag1−/−mice, 10 weeks of
age, were adoptively transferred with either CD4+ or CD8+
splenocytes isolated from age and gender matched Stat4−/−
C57Bl/6J or C57Bl/6J mice (𝑛 = 6–12/group) (Supplemental
Figure 1). Splenocyteswere enriched in eitherCD4+orCD8+
T cells by positive selection using magnetic immunosepa-
ration (StemCell Technologies, Vancouver, Canada). After
enrichment, the purity was typically >95%. 5 × 106 cells were
injected via tail vein. Some of the Rag1−/−mice were injected
with saline and served as controls. One week following the
adoptive transfer, all of the mice were placed on HFD for 15
weeks.
Mice were housed in a pathogen-free facility and indi-
vidually caged and food and water were provided ad libitum
throughout the experiment. Body weight and food intake
were measured weekly.
2.2. Metabolic Measurements. The intraperitoneal glucose
and insulin tolerance tests were performed at the end of the
chronic dietary challenge, as previously described [20, 21].
Plasma insulin was measured using a commercially available
ELISA kit from Mercodia (Uppsala, Sweden), according to
manufacturer’s instructions. Plasma glucose was measured
using a kit from Cayman Chemicals (Ann Arbor, MI). Free
fatty acids, triacylglycerols, and cholesterol were measured
with a kit fromWako (Richmond, VA).
2.3.Western Blotting for In Vivo and In Vitro Insulin Signaling.
Prior to euthanasia, mice were injected i.p. with a bolus of
10U/kg insulin or with saline and after 10 minutes adipose
tissue, liver, and muscle were harvested and homogenized
on ice in RIPA buffer with protease/phosphatase inhibitors.
To determine the activation of the insulin signaling pathway,
insulin receptor (IR), insulin receptor substrate-1 (IRS-1), and
protein kinase B (Akt) phosphorylation and total protein
expression were measured by western blotting using the
following antibodies: pIR (Y972, Abcam, 1 : 500 dil); IRbeta
(Cell Signalling, 1 : 1,000 dil); pAkt (Ser473, Cell Signalling,
1 : 1,000 dil); Akt (Cell Signalling, 1 : 1,000 dil); pIRS-1 (Y896,
Invitrogen, 1 : 500 dil); IRS-1 (Cell Signalling, 1 : 500 dil). 𝛽-
Actin (SantaCruz, 1 : 2,000 dil) was used to normalize in some
cases for protein loading. Activation of the same proteins
was also measured by western blotting in isolated adipocytes
obtained from epididymal adipose tissue following collage-
nase digestion. Adipocytes were analyzed in the basal state or
following stimulation with 5 nM insulin for 30 minutes.
2.4. Pancreatic Islet Isolation and In Vitro Glucose Stimulated
Insulin Secretion (GSIS). Pancreatic islets were isolated by
pancreatic perfusion with collagenase P (Roche Applied Sci-
ence) through the common bile duct as previously described
[21]. For GSIS islets were incubated in Krebs Ringer Bicar-
bonate Buffer (KRHB) supplemented with 3mM glucose for
1 hour followed by an additional one-hour incubation in
28mM glucose, as previously described [21].The supernatant
was collected after each of the treatments and insulin was
measured by an ELISA method (Mercodia, Uppsala, Swe-
den).
2.5. Adipose Tissue Morphometry. Epididymal tissue was
formalin fixed and paraffin-embedded and the sections were
stained with hematoxylin and eosin. Three representative
images were obtained per section, for a total of 6 tissue
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Table 1: Body weight, plasma lipids, and glucose for STAT4-deficient or STAT4-sufficient mice following bone marrow transplant.
Phenotype STAT4−/− recipient STAT4+/+ recipient 𝑝 value
Body weight (g) 31.7 ± 4.23 27.5 ± 3.87 NS
Total cholesterol (mg/dL) 188.71 ± 68.51 130.7 ± 35.5 NS
Free fatty acids (nmol/L) 0.66 ± 0.1 0.77 ± 0.18 NS
Triglycerides (mg/dL) 71.13 ± 10.85 62.13 ± 15.61 NS
Glucose (mg/dL) 150.25 ± 18.39 114.4 ± 19.15 <0.01
Results represent fasting body weights and plasma values at time of sacrifice. Data is from 𝑛 = 5–8mice/group and represents mean± SD. Statistical analysis was
performed by unpaired Student’s 𝑡-test and the null hypothesis was rejected for 𝑝 < 0.05. STAT+/+ recipient represents mice with selective STAT4 deficiency
in bone marrow cells (see Methods).
sections/mouse. Four mice/experimental group were ran-
domly selected and analyzed. Images were taken using a
Zeiss Plan Apochromat 20x objective and adipocyte area
and number were obtained using the ImageJ software (NIH,
Bethesda, MD).
2.6. Immunofluorescence Staining. Paraffin-embedded adi-
pose tissue sections were treated for antigen retrieval and
incubated with primary antibodies for STAT4 (goat anti-
mouse, Santa Cruz, CA, 1 : 100 dil) and Mac-2 (rabbit anti-
mouse, Abcam, 1 : 100 dil). Nuclei were stained using DAPI
(1 : 1,00 dil). Pictureswere taken using Zeiss PlanApochromat
20x or 40x objectives.
2.7. Adipocyte and Stromal Vascular Fraction Preparation.
Samples of epididymal adipose tissue (0.1–0.3 g) were
digested with collagenase as described before with minor
modifications [22, 23].The floating adipocytes were collected
andwashed and the infranatant was removed and centrifuged
at 500×g, for 5minutes to pellet the stromal vascular fraction
(SVF).
2.8. Flow Cytometry. Counted SVF cells were incubated for
30 minutes, at room temperature with one of the following
combinations fluorophore-conjugated primary antibodies:
Cocktail 1 (formacrophage phenotyping): CD11b-Pacific Blue,
CD45-PerCP, and Cd11c-PE F4/80-Alexa 647; Cocktail 2 (for
T cell phenotyping): CD3-Pacific Orange, CD4-APC, CD8-
FITC, and CD45-PerCP. All of the antibodies were from BD
Pharmingen (San Jose, CA) or from BioLegend (San Diego,
CA). Cells were analyzed on a BD upgraded FACS Caliber
Flow Cytometer (8 colors) using FlowJo software (Tree Star
Inc., Ashland, OR). Also spleens were collected; single cell
suspensions were prepared by gentle mechanical disruption
and were stained similarly to protocols described for SVF.
2.9. Real-Time PCR. RNA from total adipose tissue, pan-
creatic islets, adipocytes, or SVF was extracted and reverse
transcribed as previously described [24]. Real-time PCR was
performed using Taqman probes from Applied Biosystems
(Carlsbad, CA). 𝛽-Actin was used to normalize the data.
Results were expressed either as 1/ΔCt or as fold change by the
2−ΔΔCT method using the wild-type mice as a control group.
The multiplex gene array PCR for adipocytes was performed
using the Mouse Chemokine and Chemokine RT2 Profiler
PCR Array (PAMM150Z) from SA Bioscience (Carlsbad,
CA).
2.10. Statistical Analysis. Statistical analysis was performed
using GraphPad Prism Software (GraphPad Software Inc., La
Jolla, CA). Student’s 𝑡-test unpaired analysis was used for all
data comparisons between two groups (Protocols 1 and 2)
and one-way ANOVA was used for comparisons between 3
or more groups (Protocol 2). Data were expressed as mean ±
SD and the null hypothesis was rejected for a 𝑝 value < 0.05.
3. Results
3.1. STAT4-Deficiency in the Hematopoietic Compartment
Improves Glucose Tolerance and Insulin Sensitivity in Diet-
Induced Obesity. STAT4 is expressed predominantly by cells
in the myeloid and lymphoid compartments, but also in solid
organ cells including adipocytes. To determine the selective
role of STAT4 deficiency in the myeloid compartment,
C57Bl/6J mice were transplanted with bone marrow cells
(BMC) from STAT4-deficient mice (Stat4+/+ recipients) and
compared to STAT4-deficient mice transplanted with (BMC)
from wild-type littermates (Stat4−/− recipients) (Figure S1).
The degree of chimerism determined based on presence
of STAT4 gene in BMCs, blood, and spleen showed >98%
of the genetic signature of the donor cells in blood and
BMC and >85% in spleen (Figure S2). There were no
significant differences between body weights and fasting
plasma cholesterol, fatty acids, and triglycerides between
the two mice groups (Table 1). However, Stat4−/− recipi-
ent mice that received wild-type bone marrow had ∼25%
higher fasting plasma glucose compared to Stat4+/+ recipient
mice that received Stat4−/− hematopoietic cells (Table 1).
In addition, Stat4+/+ recipient mice that received Stat4−/−
BMCs showed significantly improved glucose tolerance as
determined by an intraperitoneal glucose tolerance test and
the area under curve (Figure 1). Also, the insulin tolerance test
showed improved insulin sensitivity in the mice that received
Stat4−/− BMC (Stat4+/+ recipients) (Figure 1). This result
indicates a key role of STAT4 deficiency in the hematopoietic
compartment in the improved metabolic phenotype.
3.2. Recipient Mice of STAT4-Deficient BMCs Show Reduced
Visceral Adipose Tissue Inflammation and Lymphocyte Infil-
tration in Response to High Fat Diet. Adipose tissue inflam-
mation is one of the key determinants of systemic insulin
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Figure 1: Intraperitoneal glucose tolerance test (GTT) and insulin tolerance test (ITT) were performed after 15 weeks of HFD. For both
the ITT and the GTT, STAT4−/− recipients that received STAT4+/+ bone marrow cells had significantly higher area under curve (AUC)
compared to STAT4+/+ recipients that received STAT4−/− cells. Data represents average ± SD from 7 mice/group. The null hypothesis was
rejected for a 𝑝 value < 0.05; ∗𝑝 < 0.05.
sensitivity. We previously showed that global STAT4 defi-
ciency results in reduced adipocyte hypertrophy and reduced
expression of inflammatory genes in adipocytes. However,
it was not clear whether changes in adipocyte inflammation
were the consequence of STAT4 deficiency in adipocytes or
in the immune cells infiltrating the adipose tissue. The mice
that received Stat4−/− BMC had smaller andmore numerous
adipocytes compared to ones that received STAT4-sufficient
BMC (Figures 2(a)–2(c)).This result recapitulated the finding
obtained previously in the global STAT4-deficient mice,
suggesting that hematopoietic STAT4 deficiency may have
the dominant effect on adipocyte phenotype. Indeed, analysis
of adipose tissue from the two chimeric mouse groups shows
that ∼40% of the genetic signature comes from the BMC
donor, indicating migration of the BM cells to the adipose
tissue of the recipient (Figure 2(d)). Moreover, the number
of Mac-2 positive crown-like structures (CLS) is signifi-
cantly increased in the mice that received STAT4-sufficient
BMC, suggesting increased inflammation in adipose tissue of
Stat4−/− recipients compared to the Stat4+/+ recipients that
received Stat4−/− BMCs (Figure 2(f)). Also, gene array anal-
ysis (PAMM150Z array, SA Bioscience) of Stat4−/− recipient
mice adipose tissue showed a significant increase by ∼1.3-fold
(𝑝 < 0.05) of macrophage-colony stimulating factor (Csf1),
granulocyte-colony stimulating factor (Csf3), and Tumor
Necrosis Factor (Ligand) Superfamily, Member 13b (Tnfsf13b
or BAFF) compared to Stat4+/+ recipients (Figure 2(g)). All
three of the factors are involved in differentiation and survival
of myeloid cells and B cells, respectively, suggesting that
STAT4 expression in immune cells infiltrating the adipose
tissue may be key for their local survival and proliferation.
Next, we examined the number and composition of
the T cell population and macrophage numbers in adipose
tissue of Stat4−/− compared to Stat4+/+ recipients. We
found that mice that received STAT4-sufficient hematopoi-
etic cells had significantly higher numbers of CD45+ cells,
CD3+ cells, and CD3+CD8+ cells but not CD3+CD4+
cells compared to the recipients of STAT4-deficient BMC
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Figure 2: Continued.
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Figure 2: Adipose tissue morphometry and inflammation in STAT4 chimeras after 15 weeks on HFD. Adipocyte size distribution (a) and
adipose tissue morphometry (b) were performed in 4 mice/group. Adipose tissue of STAT4−/− recipients displayed higher percentage of
large adipocytes, increased average adipocyte size, and lower cellularity. Representative micrographs of epididymal adipose tissue sections
are shown in (c). DNAwas extracted from adipose tissue and amplified with specific primers to determine STAT4 positivity. Note that STAT4
is present in adipose tissue of both chimeras indicating significant infiltration of STAT4+/+ hematopoietic cells in the STAT4−/− recipients;
histogram represents percentage of the donor cell genotype signal out of the total signal determined by densitometry of respective bands in
agarose gels (d). Representative immunofluorescence pictures of the Mac-2 positive crown-like structures (e); morphometric analysis (f) was
performed in 𝑛 = 4mice/group. The number of crown-like structures is significantly correlated with adipocyte size (𝑛 = 8mice). Gene array
containing a panel of 72 genes involved in inflammation was performed in STAT4−/− and STAT4+/+ recipients (𝑛 = 3/group) (g). Histogram
shows the three significantly increased genes in STAT4−/− recipients. Data represents average ± SD and the null hypothesis was rejected for
𝑝 < 0.05. ∗𝑝 < 0.05.
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(Figures 3(a) and 3(b)). The number of CD11b+F4/80+
macrophages as well as the number of canonical proinflam-
matory CD11b+CD11c+F4/80+ macrophages was similar in
the two mice groups (Figure 3(c)). Interestingly immunoflu-
orescence staining showed that in both groups of mice the
Mac-2 positive macrophages associated with adipose tis-
sue crown-like structures are almost always STAT4-positive
(Figure 3(d)). This may suggest a functional difference of
STAT4-expressing macrophages, such as activation level and
migratory properties that may have an impact on the overall
local inflammatory response even in absence of a difference
in cell numbers. This finding along with the STAT4 genomic
signature of CD11b+ cells isolated from adipose tissue of the
two chimeric groups also suggests that myeloablation does
not completely remove the adipose tissue resident myeloid
population (Figure 3(e)).This is also true for theCD3+Tcells,
as CD3+ cells isolated from chimeric adipose tissue show
a mixed STAT4 genomic signature (Figure 3(e)). Moreover,
in the Stat4−/− recipient chimeras, the genomic signature
indicates significantly higher STAT4 expression in the CD3+
cells isolated from adipose tissue, suggesting a larger number
of BMC-derived CD3+ infiltrating cells compared to CD3+
BMC-derived cells from Stat4−/− donors. Along with the
flow cytometry data (Figure 3(a)) our results suggest that the
STAT4-expressing CD8+ cells are the most abundant CD3+
cells infiltrating adipose tissue in response to high fat diet.
3.3. Insulin Signaling in Tissues of Chimeric Mice on High
Fat Diet in Response to In Vivo Insulin Challenge. To further
understand the contribution of individual tissues to overall
insulin sensitive profile of Stat4+/+ recipient mice compared
to Stat4−/− recipient mice, we analyzed activation of insulin
receptor (IR) and insulin receptor substrate-1 (IRS-1) in liver,
adipose tissue, and muscle in response to an in vivo insulin
bolus (Figure 6).We found increased activation of IR receptor
in liver and increased IRS-1 activation in muscle of Stat4−/−
recipients compared to Stat4+/+ recipients (Figure 6). This
result suggests a more robust response to in vivo insulin
challenge in mice that are STAT4-deficient in resident liver
macrophages (possibly Kupfer cells) or in STAT4-deficient
vascular cells from liver or muscle arguing for a potentially
predominant beneficial role of STAT4-deficiency in cells of
the nonhematopoietic compartment. Interestingly, there is
no difference in adipose tissue IR activation between the
two groups of chimeric mice suggesting that STAT4 in the
hematopoietic compartment does not appear to be the major
contributor to insulin signaling in adipose tissue in vivo
(Figure 6).
3.4. Role of Selective STAT4-Deficiency in CD4+ and CD8+
Cells in Metabolic Profile in Response to High Dietary Fat. To
further define the role of STAT4 in lymphocyte subsets on
the metabolic phenotype and adipose tissue inflammation,
we adoptively transferred CD4+ or CD8+ splenocytes iso-
lated from Stat4−/− mice or C57Bl6 controls into Rag1−/−
mice. Body weight, fasting triglycerides, and total cholesterol
were similar in all groups (Table 2). Also, fasting plasma
glucose was similar amongst all groups. In mice that received
Stat4−/− CD8+ cells, circulating free fatty acids were sig-
nificantly lower compared to STAT4+ CD8+ recipients and
compared to Rag1−/− controls injected with saline. Intraperi-
toneal GTT also showed an improved tolerance to glucose
challenge in Stat4−/− CD8+ mice compared to Rag1−/−
controls. The difference was borderline significant compared
to mice that received STAT4+/+ CD8+ cells (Figure 4(a)).
Insulin sensitivity was similar in all groups (Figure 4(b)).
This result suggests potentially improved insulin secretion in
response to increased glycemia. Indeed, in vitro glucose stim-
ulated insulin secretion was significantly blunted in Stat4+/+
CD8+ cells but not in CD4+ cells suggesting a potentially
negative effect of STAT4-sufficient CD8+ on insulin secretion
(Figure 4(c)).
3.5. Effect of Selective STAT4-Deficiency in CD8+ and CD4+
Cells on Islet and Adipose Tissue Inflammation. We next
determined the abundance of Stat4−/− and Stat4+/+ CD4+
and CD8+ cells in adipose tissue of adoptively transferred
mice on high fat diet. There was no difference between the
numbers of CD8+ cells in adipose tissue or spleen between
the Stat4−/− and Stat4+/+ cells (Figure 5(c)). However,
significantly reduced numbers of CD4+ cells were found in
the spleens and adipose tissue of mice that received Stat4−/−
CD4+ cells compared to mice that received Stat4+/+ CD4+
splenocytes (Figures 5(a) and 5(b)). Despite larger numbers
of CD4+ cells in Stat4+/+ versus Stat4−/− recipients, there
was no difference in several cytokines and chemokines
in adipocytes from CD4+ mice with or without STAT4
(Figure 5(e)). However a large and significant difference was
found in CCL2, CXCL10, and CCL5 in adipocytes frommice
that received Stat4+/+ CD8+ cells compared to all of the
other groups (Figure 5(e)). Similarly, islets from mice that
received Stat4+/+ CD8+ cells showed 2.5–3.5-fold higher
gene expression of the T cell cytokines CCL5 and CXCL10
(Figure 5(d)).
3.6. In Vitro and In Vivo Insulin Signaling in Adipose Tissue
of Rag1−/− Mice with Selective CD8+ or CD4+ STAT4-Defi-
ciency. We tested the adipocyte response to in vitro insulin
challenge in mice that received STAT4-sufficient or deficient
CD4+ or CD8+ splenocytes. We found that adipocytes from
mice that received CD4+ cells had a robust activation of the
IR and Akt that was independent of STAT4 (Figure 6(b)).
However, mice that received CD8+ cells showed a less robust
response. Also, IR and IRS-1 activation in adipose tissue in
response to in vivo insulin challenge showed a more robust
response in both CD4+ and CD8+ recipient mice that were
STAT4-deficient (Figure 6(c)).
4. Discussion
T cells, macrophages, and adipocytes constitute a functional
triad that undergoes significant deregulation in obesity
and are responsible for obesity-associated disorders [2, 25].
STAT4 is expressed in all of the three cell types, but cell-
specific roles in metabolic dysfunction are not clear. We
previously showed that global STAT4 deficiency improves
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Figure 3: Immune cell composition of the SVF of epididymal adipose tissue of chimeric mice onHFD. (a) SVF was stained with fluorescently
labeled anti-mouse CD45, CD3, CD4, and CD8 antibodies and analyzed by flow cytometry. Cell number was calculated based on the
corresponding antibody positivity. To determine different T cell subsets, cells in the CD45 positive gate were analyzed. Data represent mean
± SD from 𝑛 = 5mice/group. (b) Representative plots showing the general strategy for the CD45+ gating and for CD3 positivity and double
positivity for CD3CD4 and CD3CD8 within the CD45+ gate of each group. (c) Flow cytometry analysis of SVF stained for macrophage
markers CD11b and F4/80 and the APC marker CD11c. Data represents average ± SD of 5 mice. The number of positive cells was determined
within the CD45+ gate. (d) Representative immunofluorescent micrographs showing localization of STAT4 (red) and Mac-2 (green) in
epididymal adipose tissue of STAT4+/+ mice (i–iii) and STAT4−/− mice (iv–vi); (vii) shows a crown-like structure containing some cells
immunopositive for both Mac-2 and STAT4 (arrows); (viii) shows the nonimmune IgG control; magnification 200x for (i–iii), (iv–vi), and
(viii); 400x for (vii). CD11b+ andCD3+ cells were isolated from adipose tissue of chimericmice by immunoseparation andDNAwas extracted
and analyzed for presence of STAT4 gene following amplification with specific primers and separation on agarose gels. Band densitometry is
also showed and indicates presence of both STAT4-sufficient and STAT4-deficient CD3+ and CD11b+ cells in adipose tissue of both chimeras.
Table 2: Body weight, plasma lipids, and glucose.
Rag control CD4+STAT4−/−
CD4+
STAT4+/+
CD8+
STAT4−/−
CD8+
STAT4+/+
Body weight (g) 39.3 ± 2.0 44.9 ± 3.0 38.1 ± 6.3 45.4 ± 2.9 38.9 ± 5.6
Triglycerides (mg/dL) 46.1 ± 8.5 65.2 ± 13.5 111.6 ± 54.5 40.7 ± 9.5 119.8 ± 79.2
Free FA (mEq/L) 1.3 ± 0.17 0.89 ± 0.25 1.15 ± 0.25 0.68 ± 0.18∗ # 1.17 ± 0.17
Cholesterol (mg/dL) 170.9 ± 16.2 162.1 ± 16.4 231.9 ± 77.8 246.5 ± 60.5 215.2 ± 30.9
Fasting glucose (mg/dL) 265.9 ± 21.8 262.7 ± 65.8 259.6 ± 51.8 280.5 ± 92.3 265.1 ± 46.8
Results represent fasting body weights and plasma values at time of sacrifice. Data is from 𝑛 = 6–12 mice/group and represents mean ± SD. Statistical analysis
was performed using one-way ANOVA and the null hypothesis was rejected for 𝑝 < 0.05. ∗Significant compared to Rag controls (𝑝 < 0.01). #Significant
compared to CD8+STAT4+/+ mice (𝑝 < 0.05).
metabolic phenotype and reduces AT inflammation in obese
mice [17].
In this study we investigated selective STAT4 deficiency
in hematopoietic cell subsets as well as in cells from
the nonhematopoietic compartment (adipocytes) on insulin
resistance and adipose tissue inflammation in diet-induced
obesity. Our results showed a distinct role of STAT4 in
different subsets of hematopoietic cells on insulin sensitivity,
glucose tolerance, and adipose tissue inflammation. We also
determined that STAT4 deficiency in adipocytes may have an
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Figure 4: Glucose tolerance, insulin resistance, and islet insulin secretion. Rag1−/− controls and Rag1−/− mice adoptively transferred with
either STAT4−/−CD4+orCD8+orwith STAT4+/+CD4+orCD8+ cells were fed a high fat diet for 15weeks. Intraperitoneal glucose tolerance
test (GTT) (a) and insulin tolerance test (ITT) (b) were performed and area under curve (AUC) was measured for the GTT. Plotted values in
the histogram are average ± SEM from 𝑛 = 6–12 mice/group. Statistical analysis was performed using one-way ANOVA. (c) In vitro glucose
stimulated insulin secretion was measured in pancreatic islets in mice after 15 weeks onHFD. Islets were cultured overnight and subsequently
treated for 1 hr with 3mM or 18mM glucose. Insulin was measured by ELISA in the media of the islets stimulated with low or high glucose
concentration. Results represent average ± SEM from 𝑛 = 5mice/group; the null hypothesis was rejected for a 𝑝 value < 0.05.
impact on insulin signaling in insulin sensitive tissues but
has little effect on systemic insulin sensitivity and glucose
tolerance. In a first set of experiments we compared Stat4−/−
mice that received Stat4+/+ BMCs with Stat4+/+ littermates
that received Stat4−/− BMCs. In both mice, the blood and
BMC chimerism approached 100%. Bone marrow transplant
with STAT4-deficient cells in Stat4+/+ littermates resulted in
lower fasting glucose and improved insulin sensitivity and
glucose tolerance compared to Stat4+/+ bone marrow cells
transplanted into Stat4−/− mice, in the absence of a signifi-
cant change in body weight (Table 1 and Figure 1). Bone mar-
row cells in C57Bl6 mice contain ∼50% myeloid cells and ∼
18% lymphocytes [26]; however the high chimerism in spleen
suggests that both the myeloid and T/B cells are contributing
to the phenotype. Macrophages are known to substantially
contribute to adipocyte metabolism and local inflammation
via production of proinflammatory cytokines [27]. We found
a significantly higher number of crown-like structures that
were Mac-2 positive in the Stat4−/− mice that received
Stat4+/+ BMC (Figure 2) indicating increased inflammation
[28, 29]. Adipose tissuemacrophages are important contribu-
tors to insulin resistance and STAT4was shown to be required
for M1 macrophage polarization and IFN𝛾 production in
response to IL12/18 [15]. In addition, adiponectin increases
acute inflammation in macrophages in a STAT4-dependent
manner [13] and STAT4 polymorphisms associated with
increased STAT4 activation increasedmacrophage sensitivity
to cytokines in humans with systemic lupus [30]. Alto-
gether, this data suggests that macrophages lacking STAT4
may be less reactive and less responsive to cytokine chal-
lenge and therefore may display a milder proinflammatory
response. Although the total numbers of CD11b+F4/80+
cells were not different in adipose tissue between the two
groups, it is possible that STAT4-sufficient BM macrophages
that migrated into AT in response to obesity were more
proinflammatory compared to the Stat4−/− BM. Recruited
macrophages may initially remove dying adipocytes but their
activation towards an inflammatory phenotype soon results
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Figure 5: Continued.
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Figure 5: Immune composition and inflammation in epididymal adipose tissue of Rag1−/− mice following adoptive transfer and HFD. (a)
Flow cytometry analysis of leukocyte andCD4+T cells in adipose tissue stromal vascular fraction (SVF) and spleen of Rag1−/−mice following
adoptive transfer with STAT4+/+ CD4+ or with STAT4−/− CD4+ cells. The number of cells was counted in the CD45+ gate and the double
immunopositive CD3+CD4+ population was measured within the CD45+ gate. (b) Representative FACS plots illustrating the general gating
strategy. (c) Same flow cytometry protocol was applied to determine the total number of leukocytes and Cd3+CD8+ positive cells in SVF
and spleens of Rag1−/− mice adoptively transferred with STAT4+/+ CD8+ or with STAT4−/− CD8+ cells. Histograms in (a) and (c) represent
mean ± SEM from 5–7 mice/group. (d) Real-time PCR chemokine gene expression in pancreatic islets of STAT4+/+ CD8+ and STAT4−/−
CD8+ mice after 15 weeks of HFD (𝑛 = 6/group). (e) Real-time PCR gene expression of cytokines and chemokines of adipocytes isolated
from epididymal adipose tissue of adoptively transferred mice following 15 weeks of HFD (𝑛 = 6mice/group); ∗𝑝 < 0.05.
in cytokine production [23, 28]. Importantly we found that
the vast majority of the macrophages localized in the crown
structures showed STAT4-positivity (Figure 3). Interestingly,
we did find chimeric CD11b+ populations in both mice
groups, which indicated that irradiation did not result in
eradication of CD11b+ cells in adipose tissue. Therefore, it
is possible that STAT4-sufficient macrophages either resident
or recruited contribute to “healthy” remodeling of the obese
adipose tissue. However, the BM-derived macrophages that
contain STAT4 are also subject to increased activation and
produced more proinflammatory cytokines and chemokines.
Themechanismmay involve TLR4 activation inmacrophages
as it was shown that TLR4 requires STAT4 for IFN𝛾 pro-
duction in response to IL12 and ablation of TLR4 in the
myeloid compartment prevents insulin resistance in obese
mice [31]. Our finding that adipose tissue of mice that
received Stat4+/+ BMC also express increasedG-CSF andM-
CSF (Figure 2(g)) supports the notion that the myeloid cells
of the lattermicemay undergo increased local activation once
emigrated into adipose tissue or that STAT4 is required to
induce the respective genes. Also, we previously showed that
in diet-induced obesitymicewith global STAT4 deletion have
similar macrophage numbers compared to wild-type mice;
however, there were a significantly increased proportion of
the CD11b+F4/80+CD206+ cells, indicating a bias towards
the M2 phenotype [17]. Importantly, our data also suggests
that STAT4 deficiency in adipocytes exerts little effect on
adipocyte hypertrophy or overall tissue inflammation and
points towards a key role for STAT4 inmyeloid and lymphoid
cells.
Along with themyeloid cells, lymphocytes play an impor-
tant physiologic and pathogenic role in adipose tissue in
obesity. We found significantly lower numbers of CD45+ and
CD3+ lymphocytes, following high fat feeding, in adipose tis-
sue of mice that received Stat4−/− BMCs, compared to mice
that received Stat4+/+ BMCs (Figure 3(a)). Interestingly, only
the percentage and numbers of CD8+ T cells were signifi-
cantly increased in the group that received Stat4+/+ BMCs.
This finding recapitulates the datawe reported recently for the
global STAT4 deletion in obese C57Bl/6Jmice, where STAT4-
deficiency discriminately reduced the CD8+ cell numbers
andmigratory potential [17]. A recent report showed selective
increase in the numbers of IFN𝛾+CD8+ cells, but not in
the total CD8+ T cells in visceral adipose tissue of insulin
resistant obese humans [32]. STAT4 is known to play a key
role in IFN𝛾 production and Th1 lineage development [11].
Therefore, this finding not only emphasizes the potentially
dominant role of IFN𝛾-producing T cells but also suggests
that STAT4may be a key regulator of pathogenicCD8+T cells
in human obesity and insulin resistance.
In this study, we further investigated the role of STAT4
in different T cell subsets on insulin resistance and inflam-
mation using a Rag1−/− model of diet-induced obesity. We
found that glucose tolerance is significantly improved only
in mice that received CD8+ Stat4−/− cells but not CD8+
Stat4+/+ cells, compared to Rag1−/− mice. No differences
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Figure 6: Insulin signaling in chimeric mice following bone marrow transplant and in Rag1−/−mice following adoptive transfer and HFD.
(a) Chimeric mice following BMT. STAT4−/− and STAT4+/+ recipient mice (𝑛 = 3/group) were injected i.p. with a 10U/kg insulin bolus and
tissues were harvested after 10 minutes. Western blot analysis showed increased activation of the insulin receptor (pIR) in liver and insulin
receptor substrate-1 (pIRS-1) in muscle of the STAT4−/− recipient mice; no differences were found between the two groups in epididymal
adipose tissue. Data represents mean ± SD; ∗𝑝 < 0.05. ((b) and (c)) Rag1−/−mice following adoptive transfer. Adipocytes (b) were isolated
from epididymal adipose tissue of different mice groups and stimulated in vitro with 5 nM insulin, for 30min. Insulin receptor-1 and PKC
(Akt) activation were measured by western blot (𝑛 = 3-4/group). (c) Mice were injected with an insulin bolus (10U/kg) and euthanized after
10 minutes. Adipose tissue was harvested and processed immediately for western blot analysis. Results are representative for 2-3 mice/group.
were found between mice that received CD4+ STAT4-
deficient or STAT4-sufficient cells and the Rag1−/− mice
(Figure 4). Interestingly, in vitro glucose stimulated insulin
secretion showed an improved response in STAT4-deficient
CD8+ mice compared to CD8+ controls and no difference
was found between the islets of mice with or without
STAT4-deficiency in CD4+ cells. It is possible that the
reduced expression of CXCL10 and CCL5 chemokines found
in the islets of mice adoptively transferred with Stat4−/−
CD8+ cells (Figure 4) contributed to reduced infiltration
of inflammatory cells within the islets. It was previously
shown thatRag1−/−mice that receivedCD4+ lymphocytes by
adoptive transfer showed better glucose tolerance and insulin
sensitivity, but this effect was not observed for CD8+ cells
[19]. In this study, we did not see an amelioration of the
metabolic profile in mice adoptively transferred with CD4+
cells; however, we did show improved glucose tolerance
in the Rag1−/− mice adoptively transferred with STAT4-
deficient CD8+ cells. Although the numbers of CD8+ cells
were similar regardless of STAT4-deficiency in both spleens
and adipose tissue of adoptively transferredmice, chemokine
gene expressionwas significantly increased selectively inmice
that received STAT4-sufficient CD8+ cells compared to the
other groups. In addition, gene expression of CCL2, CXCL10,
and CCL5 was also increased in adipocytes isolated from
Rag1−/−mice that received CD8+ Stat4+/+ cells. It is possible
that local chemokine production impairs insulin signaling
in adipose tissue of mice that received CD8+ Stat4+/+ cells.
Indeed, although in vitro insulin stimulated adipocytes from
mice that received either STAT4-deficient or sufficient CD4+
or CD8+ cells responded robustly by activation of PKB,
in vivo insulin challenge triggered a more robust effect in
mice that received Stat4−/− CD8+ cells compared to the
other groups (Figure 6). The data point towards the selective
pathogenic role of CD8+ cells that is blunted in the absence
of STAT4 expression. Interestingly, a critical role for CD8+
in adipose tissue of diet-induced obesity on glucose tolerance
and insulin resistance was also reported in relation to CD40-
deficiency [33]. Although a direct molecular interaction was
not yet reported for CD40 and STAT4, recent studies showed
that amongst the susceptibility genes shared for both SLE and
RA are CD40 and STAT4 [34, 35]. It is therefore possible that
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STAT4-deficiency may be protective by reducing the costim-
ulatory effects of CD40 on CD8+ T cells. Future studies will
help to address further details of the molecular mechanisms
responsible for STAT4 involvement in the pathogenic role
of CD8+ cells in adipose tissue inflammation and insulin
resistance.
5. Conclusions
Collectively, our data emphasize that STAT4 in hematopoietic
cells plays a key role in adipose tissue inflammation and
insulin resistance. Myeloid STAT4-deficiency clearly reduces
inflammation and improves the metabolic profile even in
the context of STAT4 expression in adipocytes and resident
STAT4-sufficient tissue immune cells. STAT4 deficiency in
CD8+ cells ameliorates insulin resistance and chemokine
production in adipocytes and islets and improves 𝛽-cell
function. This study enhances our understanding on specific
cellular targets that would benefit from STAT4 inhibition in
vivo. The results suggest a new potential therapeutic target
to reducing adipose tissue and islet inflammation and insulin
resistance in obesity.
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